180 related articles for article (PubMed ID: 25963001)
21. Treatment decisions and adherence to guidelines in the treatment of low risk papillary carcinoma of the thyroid.
Hilly O; Stern-Shavit S; Iran S; Feinmesser R
Isr Med Assoc J; 2014 Sep; 16(9):548-52. PubMed ID: 25351011
[TBL] [Abstract][Full Text] [Related]
22. Radioactive iodine treatment for differentiated thyroid carcinoma in Japan.
Okamoto T
Surgery; 2010 Mar; 147(3):432-3. PubMed ID: 20176244
[No Abstract] [Full Text] [Related]
23. I-131 remnant ablation after thyroidectomy induced hepatotoxicity in a case of thyroid cancer.
Lin R; Banafea O; Ye J
BMC Gastroenterol; 2015 May; 15():56. PubMed ID: 25947546
[TBL] [Abstract][Full Text] [Related]
24. Extensive papillary carcinoma of the thyroid gland treated by external beam radiotherapy, surgery and postoperative radioactive iodine therapy.
Naveed A; Kanaan F; Tjernstrom NO
Eur Arch Otorhinolaryngol; 2009 Nov; 266(11):1837-9. PubMed ID: 19294401
[TBL] [Abstract][Full Text] [Related]
25. [Axillary metastasis of papillary thyroid carcinoma: report of a case].
El Khiati R; Ouaissi L; Rouadi S; Abada R; Mahtar M; Roubal M; Janah A; Essaadi M; Kadiri F
Pan Afr Med J; 2013; 16():12. PubMed ID: 24498461
[TBL] [Abstract][Full Text] [Related]
26. Disparity in the use of adjuvant radioactive iodine ablation among high-risk papillary thyroid cancer patients.
Moten AS; Zhao H; Intenzo CM; Willis AI
Eur J Surg Oncol; 2019 Nov; 45(11):2090-2095. PubMed ID: 31253543
[TBL] [Abstract][Full Text] [Related]
27. Radioiodine therapy for papillary and follicular thyroid carcinoma.
Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
[TBL] [Abstract][Full Text] [Related]
28. Anthracofibrosis Manifesting as False-Positive Iodine Accumulation in a Patient With Recent History of Thyroid Carcinoma.
Licht K; Kroegel C; Katenkamp K; Freesmeyer M
Clin Nucl Med; 2016 Apr; 41(4):336-7. PubMed ID: 26571446
[TBL] [Abstract][Full Text] [Related]
29. A comparison of low versus high radioiodine administered activity in patients with low-risk differentiated thyroid cancer.
Ben Ghachem T; Yeddes I; Meddeb I; Bahloul A; Mhiri A; Slim I; Ben Slimene MF
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):655-660. PubMed ID: 27225282
[TBL] [Abstract][Full Text] [Related]
30. Should radioactive iodine therapy be administrated in patient of papillary thyroid carcinoma?
Zhao J; Dong J; Sun Q; Wang H; Zhang Z; Zhou X; Liao L
Chin Med J (Engl); 2014; 127(16):3039-40. PubMed ID: 25131255
[No Abstract] [Full Text] [Related]
31. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
[TBL] [Abstract][Full Text] [Related]
32. Incidental Gallbladder Cancer Visualized From Posttreatment 131I Whole-Body Scan.
Anongpornjossakul Y; Utamakul C; Chamroonrat W; Kositwattanarerk A; Thamnirat K; Sritara C
Clin Nucl Med; 2016 Mar; 41(3):e162-3. PubMed ID: 26447377
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectives.
Scott E; Learoyd D; Clifton-Bligh RJ
Future Oncol; 2016 Nov; 12(22):2603-2613. PubMed ID: 27387641
[TBL] [Abstract][Full Text] [Related]
34. Papillary thyroid cancer: factors involved in restaging N1 disease after total thyroidectomy and radioactive iodine treatment.
Guy A; Hirsch D; Shohat T; Bachar G; Tirosh A; Robenshtok E; Shimon I; Benbassat CA
J Clin Endocrinol Metab; 2014 Nov; 99(11):4167-73. PubMed ID: 25157544
[TBL] [Abstract][Full Text] [Related]
35. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
[TBL] [Abstract][Full Text] [Related]
36. Discussion.
J Am Coll Surg; 2015 Apr; 220(4):625-7. PubMed ID: 25797748
[No Abstract] [Full Text] [Related]
37. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
38. Radioactive iodine ablation may not decrease the risk of recurrence in intermediate-risk papillary thyroid carcinoma.
Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
Endocr Relat Cancer; 2016 May; 23(5):367-76. PubMed ID: 26917553
[TBL] [Abstract][Full Text] [Related]
39. VISUAL VIGNETTE.
Narwani V; Kempf J; Lubitz S
Endocr Pract; 2017 May; 23(5):633. PubMed ID: 27631845
[No Abstract] [Full Text] [Related]
40. Metachronous solitary metastasis of papillary thyroid cancer in the cavernous sinus: case report and review of literature.
Chandarana MN; Epari S; Chaukar D; Moiyadi AV
J Cancer Res Ther; 2012; 8(3):436-8. PubMed ID: 23174730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
